Vivodyne Develops World’s Largest Biological Data Center for Drug Testing

Vivodyne has established a biological data center featuring 12 robotic laboratories named HIVE, capable of testing 3.1 million human tissues each year. By producing over 20 functional tissue types, including liver and lung, Vivodyne seeks to enhance drug screening efficiency and reduce reliance on animal testing, where 90-95% of drug candidates fail in human trials after successful animal studies.

Regulatory changes, such as the FDA Modernization Act 2.0, support the shift toward alternative testing methods, creating opportunities for companies delivering credible solutions. However, while promising, the technology currently serves as a preliminary filter rather than a complete substitute for living organisms, with ongoing research needed to fully replicate biological complexities.